Biomedical research is undergoing a transformative shift, driven by the advent of engineered human tissue models that are revolutionizing our understanding of human biology, disease mechanisms, and therapeutic responses. Breakthroughs in organoid technology and next-generation New Approach Methodologies (NAMs) are enabling unprecedented levels of multicellular complexity, functional maturation, and physiological relevance—bridging the gap between experimental systems and the intricate realities of human health and disease. In recognition of these advances, both the FDA and EMA have recently endorsed the use of NAMs and organoids in the preclinical development of new therapeutics, underscoring the urgency of advancing human-relevant methodologies and setting new standards for translational research.

This upcoming symposium will explore how these innovations are reshaping disease modeling, drug discovery, toxicity testing, and clinical translation, expanding the boundaries of what human-relevant research can achieve. The symposium will bring together leaders from academia, industry, and the clinic to share breakthroughs in tissue engineering, biofabrication strategies, microenvironment design, and platforms for reproducible and standardized model generation. 

Key themes include:

• Engineering multicellular complexity and functional maturation in human tissue models
• Advances in tissue engineering, biofabrication, and microenvironment design
• Disease modeling using organoids and NAMs
• Drug discovery and toxicity testing with human-relevant platforms
• Patient-derived models and avatars for clinical testing and precision medicine
• Regulatory pathways, model qualification, and biomanufacturing challenges

We invite you to be part of this conversation as we chart the future of human tissue models and their path to widespread adoption. Together, we can accelerate the translation of engineered human systems into tools that transform biomedical research, reduce reliance on animal models, and ultimately improve patient outcomes.